NKX2-3 and colorectal cancer: A study has found that NKX2-3 could regulate the Wnt signaling pathway and then play a critical role in the pathogenesis of colorectal cancer and could be a new biomarker for clinical practice, including early diagnosis and subsequent therapy [33, 34].